Stay updated on Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in HAE Clinical Trial page.

Latest updates to the Lanadelumab in HAE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 is added, and the prior notices about government funding status and the Revision: v3.4.1 are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedA site-wide banner about government funding lapse and current operating status was added, with links to cc.nih.gov and opm.gov. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check28 days agoChange DetectedUI updates include a new 'Show glossary' option and explanatory text about color-coding of changes. The page also shows updated revision/version information.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 appears in the study record history, replacing the prior v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.3.3 was added to the history, and the HHS Vulnerability Disclosure and revision v3.3.2 were removed from the history.SummaryDifference0.2%

- Check85 days agoChange DetectedA new site revision label 'v3.3.2' is shown on the page, replacing the previous 'v3.3.1'. This update does not alter study data, page content, or required actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in HAE Clinical Trial page.